0954.Hk
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company's capital structure is characterized by a debt-to-equity ratio of 1.04, indicating a relatively balanced mix of debt and equity financing. However, the liquidity position is weak, as evidenced by a current ratio of 0.5, which is below the industry median and suggests limited short-term liquidity to cover immediate obligations. The company reported negative net income of -66.76 million CNY and an operating loss of -48.37 million CNY, reflecting a challenging operating environment. Free cash flow is also negative at -23.07 million CNY, indicating that the company is not generating sufficient cash from operations to fund its capital expenditures.
Profitability metrics are significantly below industry norms, with a return on equity (ROE) of -12.92% and a return on assets (ROA) of -5.66%. These figures suggest that the company is not effectively utilizing its equity or assets to generate returns, and its performance is underperforming relative to the industry median. Gross profit of 17.83 million CNY is minimal compared to revenue of 556.93 million CNY, indicating low margins and potential pricing or cost control issues.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or supply chain disruptions. The absence of segment-specific data limits the ability to assess the performance of individual product lines or markets.
Looking ahead, the company's growth trajectory is uncertain. Revenue for the current fiscal year is expected to remain flat or decline, with no significant growth drivers identified in the available data. The operating loss and negative net income suggest that the company may need to implement cost-cutting measures or seek additional financing to sustain operations. The capital expenditure of -8.83 million CNY indicates ongoing investment in infrastructure, but the negative free cash flow suggests that these investments are not yet generating positive returns.
The company faces several risk factors, including liquidity constraints and the potential for dilution. The risk assessment indicates a medium liquidity risk, with the company's net cash position being negative after accounting for total debt. The dilution risk is currently low, but the company's need for additional financing could increase this risk in the future. The risk assessment also highlights the importance of monitoring the company's debt levels and cash flow generation to assess its ability to meet obligations.
Recent events, including the latest financial results and analyst estimates, indicate a challenging operating environment. The last actual EPS was 0.10 CNY, and the last actual revenue was 320.69 million CNY, both of which are below the company's total revenue for the period. These figures suggest that the company is not meeting its financial targets and may need to take corrective actions to improve performance.
- The company is experiencing significant financial distress, with negative net income and operating income.
- The debt-to-equity ratio is 1.04, indicating a balanced but potentially risky capital structure.
- The company's liquidity position is weak, with a current ratio of 0.5.
- Profitability metrics are below industry norms, with a return on equity of -12.92% and a return on assets of -5.66%.
- The company's revenue is concentrated in a single segment, increasing exposure to regional economic downturns.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 0954.HK Market data — financials · 2026-05-26
- Changmao Biochemical Engineering Co Ltd Market data — analyst estimates · 2026-05-26